Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
Kenneth K. C. Man, Alexander Häge, Tobias Banaschewski, Sarah K. Inglis, Jan K. Buitelaar, Sara Carucci, Marina Danckaerts, Regina Dittmann, Bruno Falissard, Peter Garas, Chris Hollis, Kerstin Konrad, Hanna Kovshoff, Elizabeth B. Liddle, Suzanne McCarthy, Antje Neubert, Péter Nagy, Éric Rosenthal, Edmund Sonuga‐Barke, Alessandro Zuddas, Ian Chi Kei Wong, David Coghill, Tessa Couper, Gabriele Masi, Antonella Gagliano, Marco Lamberti, Dino Maschietto, Antonella Costantino, Paola Morosini, Maria Elisa Fazzi, Klaus-Ulrich Oehler, Martina Pitzer, Jörg M. Fegert, Frank Häßler, Tobias Renner, Fabian Härtling, Marcel Romanos, Adam Alfred, Veit Roessner, Susanne Wallitza, Henrik Uebel-von Sandersleben
Topics & Concepts
MethylphenidateTolerabilityAttention deficit hyperactivity disorderMedicinePsychiatryMental healthPediatricsAtomoxetineAdverse effectClinical psychologyPsychologyInternal medicineAttention Deficit Hyperactivity DisorderNeuroethics, Human Enhancement, Biomedical InnovationsNeuroscience and Neural Engineering